hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06318455, orgStudyIdInfo id: İstanbul University-Cerrahpaşa, briefTitle: The Effect of Breathing Exercise on Sleep and Stress Levels in Women With Breast Cancer Receiving Chemotherapy Treatment, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-11-01, primaryCompletionDateStruct date: 2024-04-30, completionDateStruct date: 2024-04-30, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: University of Yalova, class: OTHER, descriptionModule briefSummary: Women receiving chemotherapy have poor sleep quality and high stress levels. With a method such as breathing exercise, which can be applied at any time without side effects, positive improvements in women's sleep and stress levels can be recorded., conditionsModule conditions: Women Receiving Chemotherapy, conditions: 18 Years of Age and Above, conditions: Women With High Stress Levels, conditions: Women With Poor Sleep Quality, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 65, type: ESTIMATED, armsInterventionsModule interventions name: Breathing exercise, outcomesModule primaryOutcomes measure: anxiety state scale, eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of İstanbul-cerrahpaşa (IUC), status: RECRUITING, city: Istanbul, country: Turkey, contacts name: Gürcan Solmaz, PhD, role: CONTACT, phone: +90 5556287897, email: gurcansolmaz@hotmail.com, contacts name: Gürcan Solmaz, role: CONTACT, phone: +90 5556287897, email: gurcansolmaz@hotmail.com, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06318429, orgStudyIdInfo id: diabet, briefTitle: Evaluation of the Effect of Stretching Exercises Applied to Diabetes Patients on Physiological Parameters and Compliance to Treatment: A Randomized Controlled Study, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-30, primaryCompletionDateStruct date: 2024-06-30, completionDateStruct date: 2024-06-30, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: University of Yalova, class: OTHER, descriptionModule briefSummary: This research will be carried out as a pretest-posttest randomized controlled study to determine the effect of stretching exercises performed 2 days a week for 12 weeks for one hour each session on physiological parameters and treatment compliance in individuals with diabetes., conditionsModule conditions: Individuals With Diabetes, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: stretching exercise group, outcomesModule primaryOutcomes measure: blood sugar, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of İstanbul-cerrahpaşa (IUC), city: Istanbul, country: Turkey, contacts name: GÜRCAN Solmaz, PhD, role: CONTACT, phone: +90 5556287897, email: gurcansolmaz@hotmail.com, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06318416, orgStudyIdInfo id: HSR230382, briefTitle: Precision Rifampin Trial for Personalized Dosing, acronym: P-RIF, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07-01, primaryCompletionDateStruct date: 2027-01-30, completionDateStruct date: 2028-01-30, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-21, sponsorCollaboratorsModule leadSponsor name: University of Virginia, class: OTHER, collaborators name: Haydom Lutheran Hospital, collaborators name: Rutgers University, descriptionModule briefSummary: Individual pharmacokinetic variability is an important driver of tuberculosis (TB) treatment failure particularly among undernourished populations, and that suboptimal serum drug concentrations are associated with delayed response to treatment, death, and acquired bacterial drug resistance. Serum drug exposures can be approximated by urine excretion as measured by spectrophotometry, replacing the need for specialized equipment for serum testing. Anti-TB pharmacokinetic variability has also been associated with enteric pathogen burden. The overall hypothesis is that urine spectrophotometry will identify people with below-target rifampin serum concentrations, which can be corrected to target levels after dose adjustment as confirmed by serum mass spectrometry. Therefore, this protocol includes a clinical trial to assess efficacy and safety of rifampin dose adjustment based on urinary excretion levels among adults and children who are being treated for drug-sensitive pulmonary TB at our longstanding collaborative research site in Haydom Lutheran Hospital, Tanzania., conditionsModule conditions: Tuberculosis, designModule studyType: INTERVENTIONAL, phases: PHASE1, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: DIAGNOSTIC, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: urine spectrophotometry for rifampin absorbance, outcomesModule primaryOutcomes measure: Rifampin serum area under the concentration time curve for the 24 hour dosing interval, primaryOutcomes measure: Adverse events, secondaryOutcomes measure: Time to sputum culture conversion to negative, secondaryOutcomes measure: Weight change, eligibilityModule sex: ALL, minimumAge: 3 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06318403, orgStudyIdInfo id: 177012, briefTitle: Estradiol Supplementation and Rotator Cuff Repair, acronym: ESTRCR, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2025-04, primaryCompletionDateStruct date: 2028-03, completionDateStruct date: 2028-05, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-28, sponsorCollaboratorsModule leadSponsor name: University of Utah, class: OTHER, descriptionModule briefSummary: Rotator cuff tears in the shoulder are common, often cause pain and disability, often fail to heal with surgery, and both tears and failure of healing are associated with estradiol deficiency. In this study, women who have gone through menopause will be randomized to either estradiol patches or placebo patches after repair of the rotator cuff. The purpose of this study is to determine whether estradiol patches show promise in improving shoulder pain, strength, and function when given with rotator cuff repair., conditionsModule conditions: Rotator Cuff Tears, conditions: Rotator Cuff Injuries, conditions: Rotator Cuff Syndrome, conditions: Menopause Related Conditions, conditions: Menopause, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 58, type: ESTIMATED, armsInterventionsModule interventions name: Transdermal estrogen, interventions name: Rotator Cuff Repair Surgery, outcomesModule primaryOutcomes measure: American Shoulder and Elbow Surgeons (ASES) Score, secondaryOutcomes measure: Simple Shoulder Test (SST) Score, secondaryOutcomes measure: Visual Analogue Score (VAS) for pain, secondaryOutcomes measure: Magnetic Resonance Imaging (MRI) tendon healing, secondaryOutcomes measure: Strength Assessment, secondaryOutcomes measure: Range of motion, otherOutcomes measure: Serum Hormone Measurement, otherOutcomes measure: Patch Count, otherOutcomes measure: Averse Event Assessment, eligibilityModule sex: FEMALE, minimumAge: 40 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06318390, orgStudyIdInfo id: 2023-0271, briefTitle: The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-08-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-08-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: The University of Texas at Arlington, class: OTHER, descriptionModule briefSummary: The primary objectives of this application are to 1) investigate the effect of increased daily consumption of the Keto5 XOGenius beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. And 2) to investigate the effect of daily consumption of the Keto5 XOGenius beverage on the following variables: waist circumference, body weight, and body mass index (BMI)., conditionsModule conditions: Cardiovascular Diseases, conditions: Hypertension, conditions: Cognitive Decline, conditions: Diet, Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: XO Genius, outcomesModule primaryOutcomes measure: Endothelial Function, primaryOutcomes measure: Neurocognitive Function, primaryOutcomes measure: Peripheral blood pressure (systolic, diastolic, mean), primaryOutcomes measure: Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG), primaryOutcomes measure: Arterial stiffness, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: UT Arlington - Science and Engineering Innovation and Research Building, status: RECRUITING, city: Arlington, state: Texas, zip: 76019, country: United States, contacts name: Robert M Brothers, PhD, role: CONTACT, phone: 817-272-3288, email: matthew.brothers@uta.edu, contacts name: Alison Mancera, BS, role: CONTACT, phone: 8172723288, email: alison.mancera@mavs.uta.edu, geoPoint lat: 32.73569, lon: -97.10807, hasResults: False
protocolSection identificationModule nctId: NCT06318377, orgStudyIdInfo id: 2022-0541, briefTitle: Peanuts and Neurocognitive / Cardiovascular Health in Black Individuals, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-09-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-08-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: The University of Texas at Arlington, class: OTHER, descriptionModule briefSummary: The overall research objective of this proposal is to determine the impact of increased daily peanut consumption on indices of neurocognitive and physiological health in BL individuals, conditionsModule conditions: Cardiovascular Diseases, conditions: Hypertension, conditions: Cognitive Decline, conditions: Diet, Healthy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, interventionModelDescription: Individual will be randomly assigned either an experimental or a control condittion, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Peanut group, outcomesModule primaryOutcomes measure: Endothelial Function, primaryOutcomes measure: Neurocognitive Function, primaryOutcomes measure: Peripheral blood pressure (systolic, diastolic, mean), primaryOutcomes measure: Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG), primaryOutcomes measure: Arterial stiffness, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: UT Arlington - Science and Engineering Innovation and Research Building, status: RECRUITING, city: Arlington, state: Texas, zip: 76019, country: United States, contacts name: Robert M Brothers, PhD, role: CONTACT, phone: 817-232-3156, email: matthew.brothers@uta.edu, contacts name: Alison Mancera, role: CONTACT, phone: 817-232-3156, email: alison.mancera@mavs.uta.edu, geoPoint lat: 32.73569, lon: -97.10807, hasResults: False
protocolSection identificationModule nctId: NCT06318364, orgStudyIdInfo id: TJ-IRB202402016, briefTitle: Postoperative Delirium in the Post-anesthesia Care Unit, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-20, primaryCompletionDateStruct date: 2024-12-30, completionDateStruct date: 2024-12-30, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Qin Zhang, class: OTHER, collaborators name: National Natural Science Foundation of China, descriptionModule briefSummary: This study aims to investigate the incidence of postoperative delirium (POD) in the PACU and analyze its influencing factors, in order to provide theoretical basis for early screening and intervention for high-risk POD population. Blood samples of some study subjects will be collected and analyzed using molecular detection methods to provide a basis and insights into the pathophysiological mechanisms of POD., conditionsModule conditions: Delirium, Postoperative, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 3320, type: ESTIMATED, armsInterventionsModule interventions name: NO Intervention, outcomesModule primaryOutcomes measure: Postoperative delirium, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: The First Hospital of Harbin Medical University, status: RECRUITING, city: Harbin, state: Heilongjiang, zip: 150000, country: China, contacts name: Yuting Liu, role: CONTACT, phone: Hongyan, email: qin4298@sina.com, contacts name: Yuting Ma, role: CONTACT, phone: 3680, email: qin4298@sina.com, geoPoint lat: 45.75, lon: 126.65, locations facility: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, status: RECRUITING, city: Wuhan, state: Hubei, zip: 430030, country: China, contacts name: Xiao Ran, phd, role: CONTACT, phone: 15926207366, email: ranxiao1001@tjh.tjmu.edu.cn, contacts name: Qin Zhang, phd, role: CONTACT, phone: 15717154768, email: qzhang8@tjh.tjmu.edu.cn, contacts name: Qin Zhang, phd, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 30.58333, lon: 114.26667, hasResults: False
protocolSection identificationModule nctId: NCT06318351, orgStudyIdInfo id: TJ-IRB202402015, briefTitle: Transcutaneous Acupoint Electrical Stimulation and Postoperative Delirium Delirium, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-12-30, completionDateStruct date: 2025-08-30, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-04-09, sponsorCollaboratorsModule leadSponsor name: Qin Zhang, class: OTHER, collaborators name: National Natural Science Foundation of China, descriptionModule briefSummary: Investigating postoperative delirium in patients undergoing thoracoscopic lung resection surgery who have received or not received relevant transcutaneous acupoint electrical stimulation treatment preoperatively, observing postoperative recovery quality indicators, evaluating the necessity of treatment, and clarifying the potential mechanisms by which transcutaneous acupoint electrical stimulation may improve postoperative delirium., conditionsModule conditions: Delirium, Postoperative, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 476, type: ESTIMATED, armsInterventionsModule interventions name: transcutaneous acupoint electrical stimulation, outcomesModule primaryOutcomes measure: Delirium, secondaryOutcomes measure: Recovery, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Guangdong Hospital of Traditional Chinese Medicine, status: NOT_YET_RECRUITING, city: Guangzhou, state: Guangdong, zip: 510000, country: China, contacts name: Jiemin Deng, role: CONTACT, phone: 2780, email: qin4298@sina.com, contacts name: Jiemin Deng, role: CONTACT, geoPoint lat: 23.11667, lon: 113.25, locations facility: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, status: RECRUITING, city: Wuhan, state: Hubei, zip: 430030, country: China, contacts name: Qin Zhang, phd, role: CONTACT, phone: 15717154768, email: qzhang8@tjh.tjmu.edu.cn, contacts name: Qin Zhang, phd, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 30.58333, lon: 114.26667, hasResults: False
protocolSection identificationModule nctId: NCT06318338, orgStudyIdInfo id: UPCC 14523, secondaryIdInfos id: 854756, type: OTHER, domain: Penn IRB, briefTitle: Virtual Reality to Promote Relaxation Prior to Simulation, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-03, completionDateStruct date: 2025-03, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Abramson Cancer Center at Penn Medicine, class: OTHER, descriptionModule briefSummary: The purpose of this study is to assess the feasibility of a pre-simulation virtual reality (VR) platform designed to promote relaxation for cancer patients planned for radiation therapy (RT)., conditionsModule conditions: Cancer, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 25, type: ESTIMATED, armsInterventionsModule interventions name: Virtual Reality Program, outcomesModule primaryOutcomes measure: Feasibility of a pre-simulation VR platform prior to radiation, secondaryOutcomes measure: Patient feedback on pre-simulation VR program, secondaryOutcomes measure: Patient situational anxiety prior to and after use of VR program, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Perelman Center for Advanced Medicine, status: RECRUITING, city: Philadelphia, state: Pennsylvania, zip: 19104, country: United States, contacts name: Ching Lai, role: CONTACT, phone: 267-250-9244, email: Ching.Lai@pennmedicine.upenn.edu, geoPoint lat: 39.95233, lon: -75.16379, hasResults: False
protocolSection identificationModule nctId: NCT06318325, orgStudyIdInfo id: ADINEGEV-2021_102, briefTitle: Growth Process and Development of the Musculoskeletal System in Young Gymnasts, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2026-03-15, completionDateStruct date: 2026-03-15, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: University of Haifa, class: OTHER, collaborators name: The Academic college Levinsky-Wingate at the Wingate Institute, Netanya, Israel, descriptionModule briefSummary: assessment of the musculoskeletal system will be performed twice a year, for three years of young gymnasts., conditionsModule conditions: Development, Adolescent, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 200, type: ESTIMATED, armsInterventionsModule interventions name: examination, outcomesModule primaryOutcomes measure: ultrasound tissue characterized, primaryOutcomes measure: muscle strength test, primaryOutcomes measure: range of motion, primaryOutcomes measure: bone strength, primaryOutcomes measure: Bone Age, eligibilityModule sex: FEMALE, minimumAge: 9 Years, maximumAge: 16 Years, stdAges: CHILD, contactsLocationsModule locations facility: The Academic college Levinsky-Wingate at the Wingate Institute, status: RECRUITING, city: Netanya, country: Israel, geoPoint lat: 32.33291, lon: 34.85992, hasResults: False
protocolSection identificationModule nctId: NCT06318312, orgStudyIdInfo id: HYP_MR_2024, briefTitle: Effects of Hypoxia on Cognitive Performance, acronym: HYPCOG, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-27, primaryCompletionDateStruct date: 2024-04-12, completionDateStruct date: 2024-05-03, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: University of Castilla-La Mancha, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to determine the effects of different hypoxia exposures (FiO2 = 11%, 13%, 15%, and 21%) on cognitive performance in healthy adults. The main questions it aims to answer are:* What is the best hypoxia exposure to improve reaction time, anticipation, attention and memory tasks?* Which hypoxia exposure causes the greatest detriments in cognitive function?, conditionsModule conditions: Hypoxia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Hypoxia, outcomesModule primaryOutcomes measure: Memory, primaryOutcomes measure: Attention, primaryOutcomes measure: Anticipation, primaryOutcomes measure: Reaction time, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, hasResults: False